tretazicar has been researched along with Liver Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonney, S; Ellis, J; Gerritsen, W; Harris, PA; Hill, S; Horne, M; Hubscher, S; Hull, D; James, ND; Kerr, DJ; Mautner, V; Mirza, D; Mountain, A; Oliff, S; Palmer, DH; Rajaratnam, R; Reynolds, G; Searle, PF; van der Sijp, JR; Young, LS | 1 |
Dexter, MT; Djeha, AH; Hulme, A; Kerr, DJ; Mountain, A; Searle, PF; Wrighton, CJ; Young, LS | 1 |
Djeha, AH; Harris, PA; Kerr, DJ; Leung, H; Mountain, A; Searle, PF; Thomson, TA; Wrighton, CJ; Young, LS | 1 |
1 trial(s) available for tretazicar and Liver Neoplasms
Article | Year |
---|---|
Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer.
Topics: Adenoviridae; Aged; Aziridines; Carcinoma, Hepatocellular; Colorectal Neoplasms; DNA Adducts; Drug Resistance, Neoplasm; Escherichia coli Proteins; Female; Flavoproteins; Gene Expression Regulation; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Half-Life; Humans; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Nitroreductases; Prodrugs; Transgenes; Virus Replication | 2004 |
2 other study(ies) available for tretazicar and Liver Neoplasms
Article | Year |
---|---|
Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954.
Topics: Animals; Apoptosis; Aziridines; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cross-Linking Reagents; Dose-Response Relationship, Drug; Escherichia coli; Head and Neck Neoplasms; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Neoplasm Transplantation; Neoplasms, Experimental; Nitroreductases; Prodrugs; Remission Induction; Time Factors; Tumor Cells, Cultured | 2000 |
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Carcinoma, Hepatocellular; Colorectal Neoplasms; Dose-Response Relationship, Drug; Escherichia coli; Gene Transfer Techniques; Genetic Therapy; Head and Neck Neoplasms; Humans; Liver Neoplasms; Luciferases; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nitroreductases; Prodrugs; Prostatic Neoplasms; Transduction, Genetic; Transfection; Tumor Cells, Cultured | 2001 |